Blackstone reportedly to sell Alinamin subsidiary for $2.2B



Blackstone Inc. will sell Alinamin Pharmaceutical Co., Ltd., its subsidiary focused on pharmaceutical products and based in Japan, to the private equity firm MBK Partners (MBKP) for $2.2 billion, Nikk…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento